# The New Age of Longevity Peptides > New Age Peptide — Longevity & Cellular Health Research Peptides — New Age Peptide maps the published research on NAD+, MOTS-c and Epitalon — three peptides studied for cellular energy, mitochondrial signaling and telomere biology in aging research. Cited summaries, no dosing advice, nothing for sale. **LONGEVITY & CELLULAR HEALTH** A citation-anchored read on NAD+, MOTS-c and Epitalon — three compounds studied for what happens inside a cell as it ages, and how far that research actually reaches. ### [NAD+](/nad) The cell's core redox coenzyme, consumed by the enzymes that repair DNA and regulate inflammation — and one of the most consistently measured declines in aging biology. ### [MOTS-c](/mots-c) A 16-amino-acid peptide encoded inside the mitochondria's own genome, linked to exercise physiology and metabolic stress response — so far almost entirely in animal studies. ### [Epitalon](/epitalon) A synthetic four-amino-acid pineal peptide studied for telomerase activity and circadian rhythm, built on one research lineage that other labs have only recently begun to replicate. ## The short version New Age Peptide is a reading desk built around three compounds that keep coming up in the same conversation about aging well: **NAD+** (nicotinamide adenine dinucleotide), **MOTS-c**, and **Epitalon**. None of them are approved medicines, and none of them are marketed here as one. What they share is an angle on the same underlying question — as cells get older, why do they get worse at making energy, repairing damage, and keeping time, and can a molecule nudge any of that back? NAD+ is a coenzyme every cell needs to burn fuel and fix DNA, and its tissue levels reliably fall with age. MOTS-c is a tiny peptide encoded inside the mitochondria themselves that appears to sense metabolic stress and push cells back toward balance. Epitalon is a synthetic four-amino-acid peptide, derived from the amino-acid pattern of a bovine pineal extract, studied for its effects on telomere length and the body's internal clock. This site walks through what the published research actually found for each one — not the marketing pitch, not the forum thread — with a citation behind every specific number. Nothing here is for sale, no dose is recommended to any person, and nothing here is medical advice. ## The new age of longevity peptides The three compounds on this desk are grouped under one frame: **the new age of longevity peptides** — NAD+, mitochondrial and pineal research. NAD+ leads the set because it has the deepest evidence base and the clearest mechanistic story: it is the cell's central redox carrier, shuttled through glycolysis and oxidative phosphorylation to make ATP, and also a substrate consumed by the sirtuins, PARPs and CD38 enzymes that govern DNA repair, gene regulation and inflammation. Tissue NAD+ decline with age is one of the more consistently observed findings in the field, partly because the NAD-consuming enzyme CD38 rises as organisms get older [4]. MOTS-c widens the frame to the mitochondrion itself. It is one of a small class of mitochondrial-derived peptides — molecules encoded not in nuclear DNA but inside the mitochondrial genome — that appear to act as stress sensors, communicating a cell's energy state back to the nucleus [12]. Epitalon widens the frame again, to the pineal gland and the circadian axis: it is studied for a proposed effect on telomerase and on melatonin synthesis, tying cellular aging to the body's sleep-wake clock [13][15]. Read together, the three sketch a rough map of where longevity research is currently looking — coenzyme depletion, mitochondrial signaling, and neuroendocrine aging — without claiming any of the three has closed the case. ## What are research peptides? *Peptides* are short chains of amino acids — the same building blocks that make up proteins, just far fewer of them strung together. MOTS-c (16 amino acids) and Epitalon (4 amino acids) are true peptides in that sense. NAD+ is not, technically: it is a *dinucleotide coenzyme*, a molecule built from two nucleotides joined by phosphate groups, and it is usually sold and studied as a small-molecule metabolite or supplement rather than a peptide. It sits on this desk because it belongs to the same longevity-research conversation, not because it shares MOTS-c and Epitalon's chemistry. All three are studied compounds, not consumer products with established safety records. MOTS-c is sold only as a research chemical, labeled not for human consumption. Epitalon is classified the same way in the US, EU and UK. NAD+ and its precursors occupy a different, messier category — legally sold as dietary supplements, with an unsettled regulatory picture for at least one precursor (NMN) and a documented contamination recall for at least one compounded injectable form. This site reports what the literature found in each case; it does not recommend using, sourcing, or dosing any of them. ## How these three fit together [**NAD+**](/nad) has the most mature human evidence of the three — multiple randomized, placebo-controlled trials of its precursors NMN and NR have shown dose-dependent increases in blood NAD+ with a generally favorable safety record [2][5], even as a major 2025 review concluded that translation to hard clinical outcomes remains limited and under-studied [1]. [**MOTS-c**](/mots-c) sits earlier on the evidence curve. Its strongest human data point is an observational association between circulating MOTS-c and mortality risk in a hemodialysis cohort [9] — real, but a long way from a clinical trial of exogenous MOTS-c in healthy adults, which does not yet exist. Everything about exercise capacity and metabolic effects comes from mouse studies [8][11]. [**Epitalon**](/epitalon) carries the deepest history and the thinnest independent replication. Its core telomerase claim traces to in-vitro work from a single research group going back to 2003 [16], with a 2025 study finally extending that result — and complicating it, in cancer cell lines — in more current cell models [14]. Its most-cited human data, an elderly-cohort mortality study, was observational rather than randomized [17]. Use the [comparison page](/compare) to see all three side by side on mechanism, evidence maturity, and regulatory status. --- This is a reading room, not a remedy — every claim traces to a cited study, and no page here sells a peptide or promises a longer life.